ZFP Therapeutic

Type: Product
Name: ZFP Therapeutic
First reported Jul 16 2014 - Updated Jul 17 2014 - 2 reports

Sangamo BioSciences Announces Second Quarter 2014 Conference Call And Webcast

/PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) today announced that the company will release its second quarter 2014 financial results after the market closes on Wednesday, July 23, 2014. The press release will be followed by a conference call ... [Published Nasdaq - Jul 16 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Analysts Review Releases Notes on Alere, AMRI, Anika Therapeutics, Nektar and Sangamo

On July 4, Analysts Review released its analysts' notes regarding Alere, Albany Molecular Research, Anika Therapeutics, Nektar Therapeutics and Sangamo Biosciences. On July 1, Alere announced the appointment of Chief Operating Officer Namal Nawana as ... [Published Individual.com - Jul 09 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

Sangamo BioSciences appoints new director

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, has appointed Stewart Parker to the company's board of directors. Ms Parker, who founded and served as President and CEO of Targeted Genetics Corporation, brings more than 30 years ... [Published Individual.com - Jun 27 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors

By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who founded and served as President and CEO of Targeted ... [Published HispanicBusiness.com - Jun 26 2014]
First reported Jun 19 2014 - Updated Jun 20 2014 - 1 reports

Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors

/PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who founded and served as President and CEO of Targeted Genetics Corporation, brings more than 30 ... [Published Michigan Live - Jun 19 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

SANGAMO BIOSCIENCES : to Present at the 2014 JMP Securities Healthcare Conference

Sangamo BioSciences' senior vice president of research and CSO, Philip Gregory , D.Phil ., will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 3:30 pm ET on June ... [Published 4 Traders - Jun 20 2014]
First reported Jun 17 2014 - Updated Jun 18 2014 - 3 reports

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

/PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an ... [Published Nasdaq - Jun 17 2014]
First reported Jun 02 2014 - Updated Jun 02 2014 - 2 reports

Sangamo gets CIRM fund to support clinical trial of ZFP Therapeutic for HIVAIDS

Sangamo BioSciences (SGMO) has announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic. ... [Published BioPortfolio - Jun 02 2014]
First reported May 30 2014 - Updated May 30 2014 - 1 reports

Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic® For HIV/AIDS

RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City ... [Published PR Newswire: General Business - May 30 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference

RICHMOND, Calif., May 29, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ... [Published PR Newswire: General Business - May 29 2014]
First reported May 15 2014 - Updated May 16 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference

RICHMOND, Calif., May 15, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and development, will provide an update on the progress of Sangamo's ... [Published PR Newswire: Health - May 15 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

Sangamo BioSciences and Collaborators to Present Data on ZFP Therapeutic Applications and Developments at Annual Meeting of the American Society of Gene and Cell Therapy

RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics® will be presented at the 17th ... [Published PR Newswire: General Business - May 14 2014]

Quotes

...Sangamo President and CEO, Edward Lanphier, stated, "We are very pleased to bring Stewart onto our Board during such an important stage in Sangamo's development. As we expand our manufacturing capabilities and advance ZFP Therapeutic programs for the development of genetic cures for monogenic diseases, Stewart's proven entrepreneurial and executive leadership skills and extensive experience in AAV gene therapy, particularly cGMP manufacturing and clinical development, will be very valuable to Sangamo."
...both genome-editing and gene regulation applications to provide potentially curative outcomes for a range of monogenic diseases," said Ms Parker. "I look forward to contributing my gene therapy knowledge and expertise, and working with the board and the rest of the Sangamo team to drive innovative ZFP Therapeutic programs toward commercialization."
NEXT ARTICLE More From BioPortfolio on "Sangamo gets CIRM fund to support clinical trial of ZFP Therapeutic for HIV AIDS"

More Content

All (21) | News (12) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Sangamo BioSciences Announces Second Quarter 20... [Published Nasdaq - Jul 16 2014]
Sangamo BioSciences Announces Second Quarter 20... [Published Wall Street Select - Jul 16 2014]
Analysts Review Releases Notes on Alere, AMRI, ... [Published Individual.com - Jul 09 2014]
Appointments, Acquisitions, Study Results, and ... [Published Town Hall - Jul 04 2014]
Sangamo BioSciences appoints new director [Published Individual.com - Jun 27 2014]
Sangamo BioSciences Appoints H. Stewart Parker ... [Published HispanicBusiness.com - Jun 26 2014]
Sangamo BioSciences appoints H. Stewart Parker ... [Published Center Watch - Jun 20 2014]
SANGAMO BIOSCIENCES : to Present at the 2014 JM... [Published 4 Traders - Jun 20 2014]
Sangamo BioSciences Appoints H. Stewart Parker ... [Published Michigan Live - Jun 19 2014]
Sangamo BioSciences Announces Presentation At T... [Published Nasdaq - Jun 17 2014]
Sangamo BioSciences : Announces Presentation At... [Published 4 Traders - Jun 17 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Jun 17 2014]
Sangamo gets CIRM fund to support clinical tria... [Published BioPortfolio - Jun 02 2014]
Sangamo gets CIRM fund to support clinical tria... [Published PBR - News - Jun 02 2014]
Sangamo BioSciences And City of Hope Granted St... [Published PR Newswire: General Business - May 30 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - May 29 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - May 15 2014]
Sangamo BioSciences and Collaborators to Presen... [Published PR Newswire: General Business - May 14 2014]
Sangamo BioSciences Announces Presentations At ... [Published PR Newswire: General Business - May 01 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Feb 26 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - Feb 06 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Jun 17 2014]
RICHMOND, Calif., June 17, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic® ...
Sangamo gets CIRM fund to support clinical tria... [Published PBR - News - Jun 02 2014]
Sangamo BioSciences (SGMO) has announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for ...
Sangamo BioSciences And City of Hope Granted St... [Published PR Newswire: General Business - May 30 2014]
RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - May 29 2014]
RICHMOND, Calif., May 29, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - May 15 2014]
RICHMOND, Calif., May 15, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and development, will provide an update on the progress of Sangamo's ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.